Status:
COMPLETED
hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics
Lead Sponsor:
IVI Vigo
Collaborating Sponsors:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
hCG
Eligibility:
FEMALE
18-32 years
Brief Summary
hCG is a hormone produced very early by the embryo, but not by the oocyte. It has a pivotal role in the trophoblast differentiation, and embryo implantation as well as the corpus luteum support. In sp...
Detailed Description
Human chorionic gonadotrophin is a two subunits (alpha and beta) glycoprotein hormone secreted by blastocyst trophoblastic cells. It plays a role in progesterone secretion by corpus luteum, endometri...
Eligibility Criteria
Inclusion
- Donors age \< 32.
- IMC\< 30kg/m2.
- Antral follicle count higher than 8.
- Single Blastocyst transference.
- 5% oxygen embryo culture,
- time-lapse monitoring incubation KID embryos.
Exclusion
- Müllerian anomalies,
- Hydrosalpinx.
- Any indication of oocyte vitrification.
- Severe male factor.
- Embryos transferences where a tenaculum was required, or more than one attempt was needed.
Key Trial Info
Start Date :
January 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 25 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04744519
Start Date
January 20 2019
End Date
June 25 2019
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Vigo
Vigo, Pontevedra, Spain, 36204